Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis.

Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis.

Item
http://www.wikidata.org/entity/Q34406863
The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach.Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study.VS-501: A NOVEL, NON-ABSORBED, CALCIUM- AND ALUMINUM-FREE, HIGHLY EFFECTIVE PHOSPHATE BINDER DERIVED FROM NATURAL PLANT POLYMERLong-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patientsPotentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysisPhosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPSCost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland.Con: Phosphate binders in chronic kidney diseasePreclinical studies of VS-505: a non-absorbable highly effective phosphate binder.Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.Sucroferric oxyhydroxide: a review in hyperphosphataemia in chronic kidney disease patients undergoing dialysis.Contemporary management of phosphorus retention in chronic kidney disease: a review.Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in maintenance hemodialysis patients.Attainment of guideline targets in EURODOPPS haemodialysis patients: are differences related to a country's healthcare expenditure and nephrologist workforce?The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial.
P2860

Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis.

Item
http://www.wikidata.org/entity/Q34406863
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@ast
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@en
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@nl
type
label
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@ast
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@en
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@nl
prefLabel
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@ast
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@en
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Serum phosphorus levels and pi ...... e in patients on hemodialysis.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932